as over 15 years of experience, from 1993 to 2008, in the pharmaceutical industry in the areas of clinical research, regulatory compliance, corporate development and management, for a variety of companies ranging from start-ups to public companies, both in Canada and in China. Prior to joining BWMT in 2010, Dr. Chen was a founder, president and chief executive officer of Welichem Biotech Inc., a Canadian pharmaceutical company listed on the TSX Venture Exchange since 2008. From 1999 until he founded Welichem, Dr. Chen was a senior scientist at Terragen Discovery Inc., a subsidiary of Cubist Pharmaceuticals. Dr. Chen received his M.Sc. and Ph.D. degrees in biology from Simon Fraser University in Vancouver, Canada in 1988 and 1991, respectively. Dr. Chen was chosen as a director because of his extensive experience in research and development, regulatory compliance, corporate development and management.
"We would like to extend our appreciation to Ms. Liu and Mr. Qiu for their valuable contribution to the Board during their tenures, and wish them every success in their future endeavors," commented Mr. Ping Chen, Chairman and Chief Executive Officer of Dehaier, "We are very pleased and honored to welcome Dr. Yang and Dr. Chen to our Board. We look forward to working with them and we believe they will bring their substantial industry and leadership experience to the Board."
About Dehaier Medical Systems Ltd.
Dehaier is an emerging leader in the development, assembly, marketing and sale of medical products in China, including respiratory and oxygen homecare medical products. The company develops and assembles its own branded medical devices and homecare medical products from third-party components. The company also distributes products designed and manufactured by other companies, including medical devices from IMD (Italy), Welch Allyn (USA), HEYER (Germany), Timesco (UK), eVent Medical (US) and JMS (Japan). Dehaier's technology is based on fiv
Page: 1 2 3 Related medicine technology :1
|SOURCE Dehaier Medical Systems Ltd.|
Copyright©2010 PR Newswire.
All rights reserved
. Dehaier Medical Systems Announces Closing of Initial Public Offering on NASDAQ2
. Dehaier Medical Systems Announces First Quarter Net Income Up 54%3
. Dehaier Medical Systems Announces New Exclusive China Distribution Agreement with Welch Allyn, Further Broadening Companys Product Lines4
. Dehaier Medical Systems Chief Executive Officer To Ring NASDAQ Stock Market Closing Bell5
. Dehaier Medical Systems to Present to Investors at Global Hunter Securities 2010 China Investor Conference in San Francisco6
. Dehaier Medical Systems Acquires Emergency Ventilator Series to Extend Product Line7
. Dehaier Medical Systems Q2 Revenue Up 46% to $4.83 Million; Net Income Up 59% to 1.14 Million; EPS 0.278
. Dehaier Medical Systems Announces Engagement of RedChip Companies to Lead Public and Investor Relations9
. Dehaier Medical Shows New Products at 2010 China International Medical Equipment Fair10
. Dehaier Medical Wins $2 Million Distribution Bid for Rural Healthcare Construction Project11
. Dehaier Medical to Participate in MEDICA International Trade Fair